Free Trial

Bruce Jackson Analyst Performance

Analyst at Benchmark

Bruce Jackson is a stock analyst at Benchmark focused in the medical sector, covering 20 publicly traded companies. Over the past year, Bruce Jackson has issued 10 stock ratings, including and buy recommendations. While full access to Bruce Jackson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bruce Jackson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
43 Last 10 Years
Buy Recommendations
86.05% 37 Buy Ratings
Companies Covered
20 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy86.0%37 ratings
Hold14.0%6 ratings
Sell0.0%0 ratings

Out of 43 total stock ratings issued by Bruce Jackson at Benchmark, the majority (86.0%) have been Buy recommendations, followed by 14.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
95.0% of companies on NASDAQ
19 companies
NYSE
5.0% of companies on NYSE
1 company

Bruce Jackson, an analyst at Benchmark, currently covers 20 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
18 companies
90.0%
Manufacturing
1 company
5.0%
Computer and Technology
1 company
5.0%

Bruce Jackson of Benchmark specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
40.0%
PHARMACEUTICAL PREPARATIONS
4 companies
20.0%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
5.0%
INSTRU - SCIENTFC
1 company
5.0%
MEDICAL LABORATORIES
1 company
5.0%
MEDICAL SERVICES
1 company
5.0%
MED/DENTAL - SUPP
1 company
5.0%
MED - DRUGS
1 company
5.0%
MED INSTRUMENTS
1 company
5.0%
MEDICAL INFO SYS
1 company
5.0%

Bruce Jackson's Ratings History at Benchmark

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CapsoVision, Inc. stock logo
CV
CapsoVision
7/28/2025Initiated Coverage$4.00$5.00Speculative Buy
Biofrontera Inc. stock logo
BFRI
Biofrontera
5/19/2025Lower Price Target$0.66$2.75Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
5/14/2025Lower Price Target$1.91$14.00Buy
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
5/13/2025Lower Price Target$0.36$3.00Speculative Buy
Clene Inc. stock logo
CLNN
Clene
5/8/2025Lower Price Target$2.66$33.00Buy
Genelux Corporation stock logo
GNLX
Genelux
5/8/2025Lower Price Target$2.49$23.00Speculative Buy
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
3/26/2025Reiterated Rating$65.18$80.00Buy
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3/24/2025Lower Price Target$0.65$4.50Speculative Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
2/27/2025Reiterated Rating$3.74Buy
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
1/21/2025Boost Price Target$60.05$79.00Buy